Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis
Objective To address the efficacy and safety of proactive therapeutic drug monitoring of biologic drugs for patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis.Design Systematic review and meta-analysis.Data sources Medline, Embase, Central, and CINAHL, from database ince...
Saved in:
Main Authors: | Eirik K Kristianslund, Dena Zeraatkar, Leticia Kawano-Dourado, Rachel J Couban, Tyler Stacy Pitre, Sarah Kirsh, Tanvir Jassal, Michael Ling, Muizz Hussain |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-10-01
|
Series: | BMJ Medicine |
Online Access: | https://bmjmedicine.bmj.com/content/3/1/e000998.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nonsteroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
by: Ingvar Bjarnason, et al.
Published: (1993-01-01) -
Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study
by: Susana Clemente Bautista, et al.
Published: (2024-12-01) -
Biosimilar biological drugs in the treatment of inflammatory bowel diseases
by: Magdalena Kaniewska, et al.
Published: (2019-12-01) -
Classification of Nanomaterial Drug Delivery Systems for Inflammatory Bowel Disease
by: Wang H, et al.
Published: (2025-02-01) -
Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management
by: Kyeong-Ryoon Lee, et al.
Published: (2024-11-01)